Two drugs before surgery help women with triple-negative breast cancer, research shows

A breast cancer specialist and clinical researcher shows that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.

Read the whole article on Science Daily

More from Science Daily